MTOR and non-small cell lung carcinoma: Furthermore, we found that Mnk inhibitor CGP57380 could abrogate RAD001-activated eIF4E phosphorylation, and the combination of Mnk inhibitor and mTOR inhibitor could augment the antitumor efficacy through inhibiting proliferation and inducing apoptosis in NSCLC cells.